SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors anticipate potential catalysts from the upcoming earnings call, with community chatter focused on a possible buyout or partnership announcement, especially with AstraZeneca, given their aligned earnings release date and recent facilities transaction. Some traders are positioning for a short squeeze due to high short interest and a decrease in available shares to borrow, while others express skepticism and frustration with management's past performance. The broader context involves speculation around the future of COVID-19 vaccines and Novavax's role in the evolving market.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending amid excitement surrounding a new partnership with Perplexity AI, which includes a $400 million deal and integration of AI search into Snapchat. The community is discussing the potential for this deal, combined with a stock buyback program, to signal a turnaround and re-rate the stock, especially given Snap's large user base and AI initiatives. Some traders are anticipating a short squeeze and upgrades from analysts.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo ($DUOL) is trending as investors debate the impact of AI on its language learning platform. While some fear free AI translation apps could disrupt their business, others argue that language learning is irreplaceable and see long-term value, especially with growing revenue and user numbers. Community discussions also revolve around the recent stock drop following earnings, with some viewing it as a manipulation and buying opportunity.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as investors assess the impact of recent earnings and guidance, with debates focusing on long-term profitability and growth potential. Community members are weighing the company's AI integration and potential for a short squeeze against concerns about valuation and lock-up periods. The stock's performance relative to peers and broader market trends is also a key talking point.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as investors discuss the company's potential in AI-driven infrastructure and smart city solutions, fueled by significant contracts and growing institutional confidence. Community members highlight the favorable risk-reward asymmetry and upcoming earnings as potential catalysts. Some traders express frustration with recent price action, while others remain optimistic about the long-term prospects and potential acquisition.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending as the community debates its potential amid discussions of buybacks and token unlocks scheduled for February. Some investors express concerns about competitor influence, particularly from $BNB and $ASTER, while others champion $AVNT as a Coinbase-backed project with a live buyback dashboard and locked developer tokens. Traders are watching key price levels, anticipating volatility and potential for a short squeeze.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending as investors anticipate upcoming earnings, with many expecting strong results driven by growth, distribution, and the Alani Nu acquisition. The community is closely watching for a potential breakout and discussing the possibility of a run-up leading to earnings. Some traders believe the stock is being manipulated, presenting a buying opportunity before a potential surge.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending amid speculation around potential partnerships and recent insider buying, with community members closely watching resistance levels. SoftBank's earlier interest in a takeover is resurfacing in discussions. Despite sector tailwinds, the stock's YTD performance remains a key talking point.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as analysts weigh in following recent earnings and amid some volatility related to data privacy concerns and short-seller reports. The community is actively discussing price targets, potential SEC investigations, and the company's growth prospects in the mobile gaming and e-commerce sectors, with some anticipating a continued climb while others remain cautious.

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

BGM Group Ltd. - Ordinary Shares - Class A

BGM Group Ltd

BGM is trending amid community discussions about its potential in AI and robotics, with some viewing it as an undervalued play in the sector. Community members are closely watching for a breakout, citing technical indicators and recent acquisitions as potential catalysts. Some traders believe BGM's strategic shift and consolidation in the AI landscape positions it for significant growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates

CareDx (CDNA) delivered earnings and revenue surprises of +115.38% and +5.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY...

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia Co-Diagnostics to Host Fireside Chat on November 5th...

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules Co-Diagnostics, Inc. Announces Closing of $7.0 Million...

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules Co-Diagnostics, Inc. Announces Pricing of $7.0 Million...

<ul class="summary-bullets"><li>The newly formed joint venture with Arabian Eagle will be called CoMira Diagnostics.</li><li>It will focus on researching, developing, manufacturing, and distributing Co-Diagnostics’ molecular diagnostic technologies.&nbsp;</li><li>The venture is looking to expand its footprint in Saudi Arabia and 18 additional Middle East and North Africa countries.</li></ul>Shares of Co-Diagnostics (CODX) more than doubled in Monday morning trading following news of a joint venture with Saudi Arabia-based Arabian Eagle Manufacturing.&nbsp;<a href="http://stocktwits.com/symbol/CODX">CODX’s stock</a> was up more than 148% in the morning trade, reaching levels not seen in more than a year. Retail interest on Stocktwits jumped to ‘extremely bullish’ from ‘bearish’ territory as chatter accelerated from ‘low’ to ‘extremely high’ levels over the past day.&nbsp;<h2 class="st-heading-2">CoMira Diagnostics To Target MENA Region</h2>The newly formed joint venture, CoMira Diagnostics, will focus on researching, developing, manufacturing, and distributing Co-Diagnostics’ molecular diagnostic technologies. This includes a new PCR point-of-care platform designed to deliver faster, cost-effective, and reliable diagnostics for hospitals, clinics, and healthcare providers across Saudi Arabia and 18 additional Middle East and North Africa (MENA) countries.<blockquote>“The KSA [Kingdom of Saudi Arabia] has published the key demand drivers that underpin that anticipated growth, and we believe that our cutting-edge PCR technology, along with the scope and mission of CoMira, addresses those drivers while reinforcing our resolve to close the accessibility gap between high-quality PCR diagnostics and those who need them."– Dwight Egan, CEO, Co-Diagnostics</blockquote>The company said Arabian Eagle brings regional regulatory expertise, logistics capabilities, and local operational support, while Co-Diagnostics provides the core technology and product development.&nbsp;<h2 class="st-heading-2">Bringing In The Local Expertise</h2>Co-Diagnostics said the partnership enables local production, accelerating access to testing while lowering costs and improving turnaround times for healthcare providers.&nbsp;It added that partners of the new joint venture believe that initially pursuing regulatory clearance with the Saudi Food &amp; Drug Administration (SFDA) will directly facilitate entry into many other countries in the area.By combining technology with local manufacturing capabilities, Co-Diagnostics said it aims to scale its molecular diagnostic solutions across the MENA region.CODX’s stock has gained 43% so far this year, but slipped around 13% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/eth-outperforms-btc-as-retail-sentiment-improves-ahead-of-fed-rate-decision/cLG030ZR3Mh">Ethereum Outperforms Bitcoin As Retail Sentiment Improves Ahead Of Fed Rate Decision, Trump-Xi Meeting This Week</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of stock price rising. (Source: Yuichiro Chino/Getty Images)

CODX Stock Jumped A Whopping 148% Today: What’s Driving The Super Rally? 

The newly formed joint venture with Arabian Eagle is called CoMira Diagnostics and it will focus on researching, developing, manufacturing, and distributing Co-Diagnostics’ molecular diagnostic technologies. 

Equity

Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx PCR Platform Across the Middle East

Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx PCR Platform Across the Middle East Co-Diagnostics Signs...

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh...

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing PR Newswire SALT...

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit PR Newswire SALT LAKE CITY, Oct. 13, 2025 SALT LAKE CITY, Oct. 13, 2025 /PRNewswire...

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Current Price	$0.3921
Prev Close	$0.379
Open	$0.3935
Dividend Yield	0.00%
50-Day Moving Average	$0.3967
Beta	1.42
Avg. Volume	53.41M
PE Ratio	-0.35

52-Week High	$1.55
52-Week Low	$0.2275
Market Capitalization	$23.58M
EPS (Annual)	-$1.24
Price to Book	0.34
Revenue Per Employee	$5,833.70
Enterprise Value/EBITDA	N/A

CODX
Co-Diagnostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CODX News

CODXCo-Diagnostics Inc